(Q37399071)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236116%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

review article

1 reference

title

A strategy for regulatory action when new adverse effects of a licensed product emerge (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236116%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236116%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1

Jeffrey K Aronson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236116%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Deirdre Price

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236116%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236116%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236116%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236116%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236116%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

91-98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19236116%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00002018-200932020-00002

22 January 2020

exact match

0 references

cites work

Monitoring for harms of therapy

1 reference

12 December 2020

Risk perception in drug therapy

1 reference

12 December 2020

Clarification of terminology in drug safety.

1 reference

12 December 2020

Evaluation of a new premedication protocol for administration of equine rabies immunoglobulin in patients with hypersensitivity

1 reference

12 December 2020

Joining the DoTS: new approach to classifying adverse drug reactions

1 reference

12 December 2020

Assessing the benefit-harm balance at the bedside

1 reference

12 December 2020

Monitoring in chronic disease: a rational approach

1 reference

12 December 2020

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

1 reference

12 December 2020

Making decisions about benefits and harms of medicines

1 reference

12 December 2020

Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.

1 reference

12 December 2020

Monitoring for adverse drug reactions

1 reference

12 December 2020

Multi-criteria decision analysis--a new approach to an old problem

1 reference

12 December 2020

CIOMS and ICH initiatives in pharmacovigilance and risk management: overview and implications

1 reference

12 December 2020

Willingness to accept risk in the treatment of rheumatic disease

1 reference

12 December 2020